• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION INFUSOR; PUMP, INFUSION, ELASTOMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION INFUSOR; PUMP, INFUSION, ELASTOMERIC Back to Search Results
Catalog Number 2C1154KP
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
E1: initial reporter last name: (b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that particulate matter (pm) was observed in the tubing of a multirate small volume infusor.The pm was further described as, ¿dirt particles was observed in the hose¿.This was observed before patient use.There was no patient involvement.No additional information is available.
 
Manufacturer Narrative
Additional information was added to d9, h3, h4, h6, and h10: h10: the device was received for evaluation.A visual inspection via the naked eye was performed, and a brown color particle embedded in the material of the tubing line was observed.The reported condition was verified.The particle was not in the fluid path because it was embedded in the material of the tubing line outside of the fluid pathway.A fourier transform infrared spectroscopy test was performed, and the particle was identified to be a mixture of polyvinyl chloride (pvc) and phthalate material which is the same material as the tubing.Fragment of burnt pvc (brown particle) can potentially be embedded in the material of the tubing during the manufacture of the tubing.Burnt pvc is a byproduct of the tubing material.Since the particulate matter was embedded (not in fluid path) and made of the same material as the tubing line, this is therefore a cosmetic condition.The cause of the particle was determined to be fragment of burnt pvc embedded into the tubing during the manufacturing process.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSOR
Type of Device
PUMP, INFUSION, ELASTOMERIC
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - IRVINE
17511 armstrong avenue
building 3
irvine CA 92614
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18970575
MDR Text Key338672404
Report Number1416980-2024-01317
Device Sequence Number1
Product Code MEB
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K011317
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2C1154KP
Device Lot Number21H001
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/29/2024
Initial Date FDA Received03/25/2024
Supplement Dates Manufacturer Received04/05/2024
Supplement Dates FDA Received04/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NA.
-
-